2001
DOI: 10.1006/gyno.2001.6204
|View full text |Cite
|
Sign up to set email alerts
|

Ten-Year Survival of Patients with Locally Advanced, Stage IB–IIB Cervical Cancer after Neoadjuvant Chemotherapy and Radical Hysterectomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

3
42
0

Year Published

2004
2004
2021
2021

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 64 publications
(46 citation statements)
references
References 10 publications
3
42
0
Order By: Relevance
“…Lymph node involvement in both groups was twice that was quoted for similar stage tumours in the literature. In other reports, for tumours clinically assessed as 44 cm diameter, a 11 -25% lymph node involvement resulted in overall 5-year survival figures between 82 and 74% (Eddy et al, 1995;Sardi et al, 1997;Benedetti-Panici et al, 1998;Hwang et al, 2001). Similarly, a randomised study by Chang et al (2000), comparing neoadjuvant chemotherapy followed by radical hysterectomy with radical radiotherapy in bulky stage I disease, showed a 2-year cumulative survival of 81% for the neoadjuvant chemotherapy arm, but no significant difference between that and the control arm in disease-free or overall survival.…”
Section: Discussionmentioning
confidence: 82%
See 3 more Smart Citations
“…Lymph node involvement in both groups was twice that was quoted for similar stage tumours in the literature. In other reports, for tumours clinically assessed as 44 cm diameter, a 11 -25% lymph node involvement resulted in overall 5-year survival figures between 82 and 74% (Eddy et al, 1995;Sardi et al, 1997;Benedetti-Panici et al, 1998;Hwang et al, 2001). Similarly, a randomised study by Chang et al (2000), comparing neoadjuvant chemotherapy followed by radical hysterectomy with radical radiotherapy in bulky stage I disease, showed a 2-year cumulative survival of 81% for the neoadjuvant chemotherapy arm, but no significant difference between that and the control arm in disease-free or overall survival.…”
Section: Discussionmentioning
confidence: 82%
“…In addition, it may serve to control micrometastatic disease and so improve survival. Previous studies have relied on clinical evaluation by pelvic examination with or without ultrasonography to assess the response (Eddy et al, 1995;Lai et al, 1997;Sardi et al, 1997;Benedetti-Panici et al, 1998;Hwang et al, 2001). Reductions in tumour volume of up to 100% with as many as 15 -20% having complete clinical response after three cycles of chemotherapy (Lai et al, 1997;Benedetti-Panici et al, 1998) have been reported, but on comparison with subsequent histopathology these assessments have been shown to be inaccurate (Eddy et al, 1995).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…3,10,14,20,24,25,28) If neoadjuvant chemotherapy reduces tumor volume and infiltration, surgery allows further cytoreduction, as demonstrated in solid neoplasms of other tissues such as the lung, testicle, and breast. 7,9,16) The combination of neoadjuvant chemotherapy and surgery to treat cerebral LGG has been reported only in a patient with a low-grade oligodendroglioma that progressed after prior partial surgical resection. 6) Similar to our case, chemotherapy achieved regression of the contralateral diffusion, leading to a second radical surgery.…”
Section: Discussionmentioning
confidence: 99%